Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 9, 2026, 1:07 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1417–1440 of 3,978 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Pathophysiology Clear all

Conditions: Environmental Enteric Dysfunction
Interventions: TNIB Catheter; Device
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 60 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2029
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Autism, Autistic Disorder, Child Development Disorders, Pervasive, Gastrointestinal Diseases, Signs and Symptoms, Digestive
Interventions: Oralgam (human immunoglobulin); Drug
Lead sponsor: PediaMed Pharmaceuticals; Industry
Eligibility: 2 Years to 18 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2006
U.S. locations: 22
States / cities: Phoenix, Arizona • Sacramento, California • Gainesville, Florida + 17 more

Conditions: Alzheimer's Disease
Interventions: Elenbecestat, Placebo; Drug
Lead sponsor: Eisai Co., Ltd.; Industry
Eligibility: 50 Years to 85 Years
Enrollment: 2,212 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 88
States / cities: Chandler, Arizona • Colton, California • Costa Mesa, California + 68 more

Conditions: Renal Excretion, Bacterial Infections, Inflammatory Disease, Oncologic Disease
Interventions: 11C-para-aminobenzoic acid PET/CT, Probenecid; Combination Product · Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older
Enrollment: 13 participants
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Early Memory Loss, Mild Cognitive Impairment, Alzheimer's Disease, Vascular Dementia
Interventions: CerefolinNAC®; Other
Lead sponsor: Pamlab, Inc.; Industry
Eligibility: 50 Years to 80 Years
Enrollment: 204 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Hickory, North Carolina

Conditions: Cognitive Decline
Interventions: Not listed
Lead sponsor: Lahey Clinic; Other
Eligibility: 50 Years and older
Enrollment: 170 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2017
U.S. locations: 1
States / cities: Burlington, Massachusetts

Conditions: Neurological Manifestations
Interventions: Optimizing hemodynamic and anesthetic parameters to improve cerebral perfusion; Device
Lead sponsor: Atlantic Health System; Other
Eligibility: 18 Years to 90 Years
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2009
U.S. locations: 1
States / cities: Morristown, New Jersey

Conditions: Alzheimer's Disease
Interventions: Resveratrol, Placebo; Drug
Lead sponsor: Alzheimer's Disease Cooperative Study (ADCS); Other
Eligibility: 50 Years and older
Enrollment: 119 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 26
States / cities: Phoenix, Arizona • Irvine, California • La Jolla, California + 20 more

Conditions: Meibomian Gland Dysfunction, Dry Eye
Interventions: Lipiflow Thermal Pulsation System, iLux System; Device
Lead sponsor: Epstein, Arthur B., OD, FAAO; Individual
Eligibility: 18 Years and older
Enrollment: 43 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: Alzheimer Disease, Parkinson Disease, Frontotemporal Dementia, Cortico Basal Degeneration, Posterior Cortical Atrophy (PCA), Neurological Diseases or Conditions, Dementia
Interventions: MemorEM; Device
Lead sponsor: eQ8Health Corporation d/b/a CareONE Concierge; Industry
Eligibility: 45 Years to 100 Years
Enrollment: 1,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Alzheimer's Disease
Interventions: ABBV-8E12, placebo for ABBV-8E12; Drug
Lead sponsor: AbbVie; Industry
Eligibility: 55 Years to 85 Years
Enrollment: 453 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 38
States / cities: Phoenix, Arizona • Sun City, Arizona • Irvine, California + 31 more

Conditions: Carotid Artery Disease, Carotid Artery Stenosis, Diabetes, Cognitive Dysfunction
Interventions: Carotid endarterectomy, Shunt; Procedure · Device
Lead sponsor: Columbia University; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2014
U.S. locations: 1
States / cities: New York, New York

Conditions: Infertility, Female, Obesity
Interventions: Estradiol Patches; Drug
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 38 Years · Female only
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 2
States / cities: Aurora, Colorado

Conditions: Dry Eye Syndromes
Interventions: Lifitegrast Ophthalmic, Systane Free, Lipiflow; Drug · Device
Lead sponsor: Tauber Eye Center; Other
Eligibility: Not listed
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Kansas City, Missouri

Conditions: Secondary Pulmonary Arterial Hypertension
Interventions: Heart Catheterization; Procedure
Lead sponsor: National Institutes of Health Clinical Center (CC); NIH
Eligibility: 18 Years to 100 Years
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2000 – 2009
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Eustachian Tube Dysfunction, Endolymphatic Hydrops
Interventions: Nasal steroid, Myringotomy tube placement, Diuretic, Antihistamine, Low salt diet; Drug · Procedure · Behavioral
Lead sponsor: Vanderbilt University; Other
Eligibility: 18 Years to 70 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Alzheimer Disease, Mild Cognitive Impairment, Cognitive Change, Energy Metabolism, Sleep Disturbance
Interventions: MyTAP oral appliance plus mouth shield; Device
Lead sponsor: The University of Texas at Dallas; Other
Eligibility: 55 Years to 85 Years
Enrollment: 41 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Fatty Liver, Nonalcoholic, Weight Loss, Virtual Reality, Implementation Science
Interventions: In-person dietary weight loss counseling, Virtual reality dietary weight loss counseling; Behavioral
Lead sponsor: Milton S. Hershey Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Hershey, Pennsylvania

Conditions: Depression
Interventions: Citalopram, Methylphenidate (MPH), Placebo; Drug
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 60 Years and older
Enrollment: 181 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2013
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Gastrointestinal Diseases
Interventions: Recording of Myoelectric Signals; Device
Lead sponsor: G-Tech Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 88 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: Mountain View, California

Conditions: Hypertension, Cognitive Decline
Interventions: Virtual Collaborative Care Clinic; Other
Lead sponsor: University of Kansas Medical Center; Other
Eligibility: 65 Years and older
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Kansas City, Kansas

Conditions: Attention Deficit Hyperactivity Disorder
Interventions: Not listed
Lead sponsor: Duke University; Other
Eligibility: 13 Years to 17 Years
Enrollment: 62 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2021
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: MCI, Mild Cognitive Impairment, Mild Cognitive Impairment (MCI)
Interventions: Motivationally Enhanced Compensatory Cognitive Training for Mild Cognitive Impairment (ME-CCT-MCI), Brief Motivationally Enhanced Compensatory Cognitive Training for Mild Cognitive Impairment (bME-CCT-MCI); Behavioral
Lead sponsor: University of Florida; Other
Eligibility: 65 Years to 84 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Depression, Depression During the Menopausal Transition, Menopausal Depression
Interventions: Phase Advanced Intervention (PAI), Phase Delay Intervention (PDI); Behavioral
Lead sponsor: University of California, San Diego; Other
Eligibility: 45 Years to 75 Years · Female only
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: San Diego, California

Search by objective public record fields.

OCT Guided Trans Nasal Imaging of the Small Intestine in Adults

Safety and Efficacy Study in the Treatment of Intestinal Problems Associated With Autism

A 24-Month Study to Evaluate the Efficacy and Safety of Elenbecestat (E2609) in Participants With Early Alzheimer's Disease

Biodistribution and Pathophysiology Study of 11C-para-aminobenzoic Acid

NAC-003 P.L.U.S. Program (Progress Through Learning Understanding & Support)

Evaluating the Impact of Cerebral Ischemic And Degenerative Changes On Cognition

Brain Oxygenation Monitoring in Patients Undergoing Coronary Artery Bypass Surgery

Resveratrol for Alzheimer's Disease

Lipiflow vs iLux Patient Acceptance and Comfort Study

Research Study for Patients With Neurological Diseases Which Evaluates the Patient Experience of the MemorEM Device

A Study to Evaluate the Efficacy and Safety of ABBV-8E12 in Participants With Early Alzheimer's Disease

Effect of Raised CBF During CEA on Cognition in DM Patients

Convergent Mechanisms Underlying Reprometabolic Syndrome in Women

Treatment Regimens in Meibomian Gland Dysfunction

Endothelial Cell Dysfunction in Pulmonary Hypertension

Refractory Eustachian Tube Dysfunction: Are the Symptoms Related to Endolymphatic Hydrops

Brain Energy Metabolism and Sleep in Adults

Feasibility of Immersive Virtual Reality Dietician Program in Metabolic-dysfunction Associated Steatotic Liver Disease

Effectiveness of Methylphenidate in Improving Cognition and Function in Older Adults With Depression

Gastrointestinal Myoelectric Activity Protocol, the G-Tech EEnG Protocol

Remote Monitoring and Virtual Collaborative Care For Hypertension Control To Prevent Cognitive Decline

Sleep Dysfunction and Neurocognitive Outcomes in Adolescent ADHD

Telehealth-Adapted Compensatory Training and Intervention for Cognition

Sleep and Light Intervention (SALI) for Menopausal Mood Dysfunction